Clinical Trials Insight: 700042755

Trial Profile

Clinical Trials Insight: 700042755

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2010

At a glance

  • Drugs BCG; BCG; Epirubicin
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Dec 2010 Results of this interim analysis met the criterion for statistical significance for RFS, and these results thus represented the final analysis, and the trial was terminated
    • 22 Dec 2010 Status changed from active, no longer recruiting to completed.
    • 22 Dec 2010 Primary endpoint 'Disease-free-survival-rate' has been met
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top